Detalhe da pesquisa
1.
Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice.
J Antimicrob Chemother
; 77(4): 1094-1101, 2022 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35022753
2.
Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.
J Antimicrob Chemother
; 76(12): 3280-3285, 2021 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34508640
3.
Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32868324
4.
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.
Nat Commun
; 15(1): 178, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38212337
5.
Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.
Pharmaceutics
; 14(11)2022 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36365101
6.
UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma.
J Pharm Biomed Anal
; 181: 113057, 2020 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31962247